PBS Biotech
Publication

Scalable Bioreactor-Based Suspension Approach to Generate Stem Cell-Derived Islets From Healthy Donor-Derived iPSCs

Summary

This publication evaluates a suspension differentiation process for generating stem cell-derived islets from healthy donor-derived human induced pluripotent stem cells in 0.1 L Vertical-Wheel® Bioreactors. Stage-specific characterization included pancreatic and endocrine markers, gene expression, electrophysiology, oxygen consumption, insulin secretion, transplantation outcomes, graft histology, yield, and process economics. The process generated 90.4% PDX1/NKX6.1 double-positive pancreatic progenitors and glucose-responsive islet-like cells while identifying ductal, enterochromaffin, and other off-target populations. Bioreactor culture produced approximately 105 million cells per vessel, representing a 12.7-fold increase in yield compared with the semi-planar process evaluated. The workflow also reduced the calculated cost of producing the target cell mass by 88.8%, and transplanted islet products matured in vivo and reversed diabetes in a mouse model.

This page summarizes the document. The full publication, including methods, figures and data, is available to view or download with a free account.
Access this documentSign in or create a free account to view the full publication.
Document details
DocumentPublicationCell TypeiPSC & PSC, Organoids & IsletsSystemsPBS-MiniCulture FormatAggregatesSecondary CellsStem Cell-Derived Islets, Islet-Like Cells, Pancreatic Beta Cells, Pancreatic Progenitors
Resources

How Can We Help?

Tell us what you need and we’ll take it from there.